Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.70 |
| ▸ | ESR1 | P03372 | 2/20 | 0.69 |
| ▸ | SHBG | P04278 | 1/20 | 0.69 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | SLC5A1 | P13866 | 3/20 | 0.67 |
| ▸ | SLC5A2 | P31639 | 3/20 | 0.67 |
| ▸ | GAA | P10253 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | HPGD | P15428 | 2/20 | 0.67 |
| ▸ | ATM | Q13315 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.67 |
| ▸ | TTR | P02766 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Davidigenin SCHEMBL30291870 | 1.00 | CYP19A1 (0.70) | CYP19A1ESR1SHBGESR2MEN1 | |
| SCHEMBL7301852 | 0.90 | GAA (0.66) | CYP19A1ESR1SHBGESR2MEN1 | |
| SCHEMBL30065457 | 0.90 | GAA (0.66) | CYP19A1ESR1SHBGESR2MEN1 | |
| SCHEMBL31511905 | 0.88 | CYP19A1 (0.67) | CYP19A1ESR1SHBGESR2MEN1 | |
| SCHEMBL9578017 | 0.88 | CYP19A1 (0.67) | CYP19A1ESR1SHBGESR2MEN1 | |
| SCHEMBL31511903 | 0.88 | MEN1 (0.76) | CYP19A1ESR1SHBGESR2MEN1 | |
| SCHEMBL4656453 | 0.88 | MEN1 (0.76) | CYP19A1ESR1SHBGESR2MEN1 | |
| SCHEMBL2875989 | 0.85 | KMT2A (0.69) | CYP19A1ESR1ESR2MEN1KMT2A | |
| SCHEMBL30254972 | 0.85 | KMT2A (0.69) | CYP19A1ESR1ESR2MEN1KMT2A | |
| SCHEMBL6427459 | 0.85 | HSP90AB1 (0.70) | ESR1SHBGESR2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 353 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230293614-A1 | COMPOSITIONS AND METHODS OF TREATING UPS-ASSOCIATED DISEASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-09-21 | — | — | US | claimed |
| US-20230045522-A1 | COMPOSITIONS AND METHODS TO MODULATE GLUCOSE HOMEOSTASIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-02-09 | — | — | US | claimed |
| US-11234918-B2 | Methods for botanical and/or algae extraction | BASF CORPORATION (US) | 2022-02-01 | — | — | US | claimed |
| WO-2022015740-A1 | COMPOSITIONS AND METHODS OF TREATING UPS-ASSOCIATED DISEASES | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2022-01-20 | — | — | WO | claimed |
| WO-2021113473-A1 | COMPOSITIONS AND METHODS TO MODULATE GLUCOSE HOMEOSTASIS | THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2021-06-10 | — | — | WO | claimed |
| US-20200397026-A1 | ANTIMICROBIALLY ACTIVE MIXTURES | SYMRISE AG (DE) | 2020-12-24 | — | — | US | claimed |
| EP-3709820-A1 | ANTIMICROBIALLY ACTIVE MIXTURES | Symrise AG (DE) | 2020-09-23 | — | — | EP | claimed |
| EP-2858641-B1 | IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF CORP (US) | 2017-09-06 | — | — | EP | claimed |
| US-20150140141-A1 | METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2015-05-21 | — | — | US | claimed |
| EP-2858641-A1 | IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF Corporation (US) | 2015-04-15 | — | — | EP | claimed |
| US-20080227867-A1 | USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE | SYMRISE GMBH & CO. KG (DE) | 2008-09-18 | — | — | US | claimed |
| WO-2007109217-A2 | COMPOUNDS FROM AN EXTRACT OF ARTEMISIA AND METHODS FOR TREATING DISORDERS | RUTGERS, THE STATES UNIVERSITY OF NEW JERSEY (US) | 2007-09-27 | — | — | WO | claimed |
| WO-2007107596-A1 | USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS | SYMRISE GMBH & CO. KG (DE) | 2007-09-27 | — | — | WO | claimed |
| US-20070224301-A1 | Compounds from an extract of Artemisia and methods for treating disorders | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2007-09-27 | — | — | US | claimed |
| CN-101022818-A | Physiologically active composition | CARGILL INC (US) | 2007-08-22 | — | — | CN | claimed |
| EP-1818060-A1 | Cosmetic composition comprising Fadogia ancylantha extracts | ARTSANA S.p.A. (IT) | 2007-08-15 | — | — | EP | claimed |
| EP-1784201-A2 | PHYSIOLOGICALLY ACTIVE COMPOSITION | Cargill, Incorporated (US) | 2007-05-16 | — | — | EP | claimed |
| WO-2006010560-A2 | PHYSIOLOGICALLY ACTIVE COMPOSITION | CARGILL, INCORPORATED (US) | 2006-02-02 | — | — | WO | claimed |
| US-5234951-A | Anti-ulcer agent comprising chalcone derivative | TSUMURA JUNTENDO, INC. (JP) | 1993-08-10 | — | — | US | claimed |
| EP-0292576-A1 | ANTI-ULCEROUS AGENT CONTAINING CHALCONE DERIVATIVE AS EFFECTIVE INGREDIENT AND NOVEL CHALCONE DERIVATIVES | TSUMURA & CO. (JP) | 1988-11-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11234918-B2 | Methods for botanical and/or algae extraction | ALG1, ALG8, CUTA | CYP19A1 1745/4885ESR1 4633/4885SHBG 362/4885 |
| US-20070224301-A1 | Compounds from an extract of Artemisia and methods for treating disorders | PDK2, PCK2, DUSP2 | CYP19A1 909/4885ESR1 2944/4885SHBG 2357/4885 |
| US-20080227867-A1 | USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE | TAS2R45, TAS2R43, TAS2R30 | CYP19A1 4132/4885ESR1 2960/4885SHBG 391/4885 |
| US-20230045522-A1 | COMPOSITIONS AND METHODS TO MODULATE GLUCOSE HOMEOSTASIS | GCKR, G6PC1, GPR119 | CYP19A1 1822/4885ESR1 1818/4885SHBG 245/4885 |
| US-20150140141-A1 | METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | ALG1, ALG8, CUTA | CYP19A1 1745/4885ESR1 4633/4885SHBG 362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.